asthma | Bicom Training

Specific environmental toxins in relation to the syndromes asthma, Parkinson’s and diabetes

David FranklinApril 18, 2016 Comments off

Alan E. Baklayan, Naturopath, Munich
Dear colleagues,
Once I succeeded in getting T-lymphocytes, both CD 8 and CD 14 T-lymphocytes, into ampoules as starting material, various opportunities presented themselves. The first was to test the activity of T-lymphocytes or the lack of activity of lymphocytes and the progress of this activity using BICOM’s amplification technology. The second possibility was to test specifically which immune blockages impede T-lymphocytes, which also play a signify-cant role in the cancerous process, and to treat them.

I actually managed to isolate a few environmental toxins which evidently play a crucial role. These are bleaching agents in particular. This means any bleach and also the agents used in drinking water and in sewage treatment plants to disinfect water. The second is benzene and benzopyrene, in other words benzene derivatives. The third contaminant is ball bearing grease, only slight traces of which admittedly come into households via mains w...

You are unauthorized to view this page. You must purchase Gold Membership

Clinical effect, safety and mechanisms of BICOM 2000 system to asthma in children

David FranklinApril 18, 2016 Comments off

Feng Yi Zhen, Professor of pediatrics, Liu Li Ping, Wang Jin Rong,Shandong, China

Objectives
1. To examine the allergen detection, clinical effect, safety in the near future and side effects of the BICOM® 2000 system to asthma in children.
2. To explore the mechanism of BICOM® 2000 to asthma through evaluation of the changes in serum levels of IL-4, tIgE and IFN-gamma before and after BICOM® treatment.

Methods
1. Allergen detection and desensitization A total of 124 children with asthma and 150 children with asthma associated with rhinitis were selected according to the “national standard for child asthma” formulated by the national child asthma consortium. There were 82 mild, 164 moderate and 28 severe cases. All cases had not been treated with systemic glucocorticoids, antihistaminics or immunomodulators within one week before treatment. All children received allergen test and desensitization with BICOM®, together with the standard GINA therapy, which includes 125 microgra...

You are unauthorized to view this page. You must purchase Gold Membership

Experience in treating bronchial asthma

David FranklinApril 17, 2016 Comments off

Dr. med. Jürgen Hennecke, Aachen
1. INTRODUCTION
Around 5 % of the adult population suffers from bronchial asthma. Those affected by it are becoming increasingly younger: up to 15 % of children suffer from this disorder, with bronchial asthma the most common chronic disorder in childhood. Boys are twice as likely to be affected as girls. In one third of children initial symptoms appear in the first year of their life. Conventional medical treatment is confined to treating the symptoms, which is very effective in itself but seldom tackles the cause of the disorder. BRT provides us with an excellent opportunity for therapy.

2. DEFINITION
“Bronchial asthma is an inflammatory disorder of the airways with bronchial hyperreactivity and spasmodic obstruction of the airways, usually connected with an atopic disposition.”
A differentiation is made in conventional medicine between chronic bronchitis and bronchial asthma. Our experience has shown that the same approach works for both clini...